Alnylam Pharmaceuticals (ALNY) Revenue (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) reported Revenue of $1.29 billion for Q2 2026, up 66.9% from $773.69 million a year earlier and up 10.6% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Revenue (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alnylam Pharmaceuticals' Revenue came in at $4.8 billion, up 153.1% year-over-year; for FY2025, it was $3.71 billion, up 65.2% from FY2024.
- Revenue has increased for seven consecutive years, with a five-year compound annual growth rate of 49.8% (FY2020 to FY2025).
- By year, Revenue came in at $2.25 billion in FY2024 (+23.0%), $1.83 billion in FY2023 (+76.2%), $1.04 billion in FY2022 (+22.9%) and $844.29 million in FY2021 (+71.3%).
- The Q2 2026 figure ranks as the highest quarterly Revenue in data going back to Q2 2009.
- Year over year, Revenue gained in five of the last seven quarters, with growth averaging 32.3%.
- The high point for year-over-year Revenue in five years was Q3 2023 (growth of 184.0%); the low point was Q1 2025 (a decline of 93.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.17 billion (Q1 2026), $1.1 billion (Q4 2025) and $1.25 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 1.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Bn |
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.10 Bn |
| Sep 30, 2025 | 1.25 Bn |
| Jun 30, 2025 | 773.69 Mn |
| Dec 31, 2024 | 593.17 Mn |
| Sep 30, 2024 | 500.92 Mn |
| Jun 30, 2024 | 659.83 Mn |
| Mar 31, 2024 | 494.33 Mn |
| Dec 31, 2023 | 439.72 Mn |
| Sep 30, 2023 | 750.53 Mn |
| Jun 30, 2023 | 318.75 Mn |
| Mar 31, 2023 | 319.29 Mn |
| Dec 31, 2022 | 335.04 Mn |
| Sep 30, 2022 | 264.31 Mn |
| Jun 30, 2022 | 224.82 Mn |
| Mar 31, 2022 | 213.26 Mn |
| Dec 31, 2021 | 258.54 Mn |
| Sep 30, 2021 | 187.63 Mn |
| Jun 30, 2021 | 220.55 Mn |
API Access
Alnylam Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();